Patricia Van Arnum - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Patricia Van Arnum's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Patricia Van Arnum

Patricia Van Arnum

Verified

Editorial Director, DCAT Value Chain Insights

Final Covers

veterans and the VA national politicsInvestigative reporting and feature writing on cancer breakthroughs and immunotherapy popular music and culture college sports.

Doesn’t Cover

style, trends

Journalist Type

-

Seniority Positions

-

Industries

Medium Formats

-

Content

Total articles 474

  • Unpacking the Latest on Pharma, Trade & Tariffs: What May Be Next?

    By Patricia Van Arnum Verified| DCAT Value Chain Insights Verified Unpacking the Latest on Pharma, Trade & Tariffs: What May Be Next? Global volatility on the trade front continued this week as the US put a 90-day pause on implementing its plan for reciprocal tariffs on a country-by-country basis, but uncertainty remains, particularly for certain trading partners, notably China. What is the impact on the pharma industry and what may in store.

    By Patricia Van Arnum Verified · DCAT Value Chain Insights

    Apr. 10, 2025

  • Pharma CEOs Speak on the Fallout from Evolving US–EU Trade Policy - DCAT Value Chain Insights

    By Patricia Van Arnum Verified| DCAT Value Chain Insights Verified Pharma CEOs Speak on the Fallout from Evolving US–EU Trade Policy The European Federation of Pharmaceutical Industries and Associations, representing innovator drug companies in Europe, and Medicines for Europe, representing generics and biosimilars producers in Europe, speak out on  the impact of a changing tariff scheme on the bio/pharma industry in the EU and propose action plans.

    By Patricia Van Arnum Verified · DCAT Value Chain Insights

    Apr. 10, 2025

  • Unpacking the Latest on Pharma, Trade & Tariffs: What May Be Next?

    By Patricia Van Arnum Verified| DCAT Value Chain Insights Verified Unpacking the Latest on Pharma, Trade & Tariffs: What May Be Next? Global volatility on the trade front continued this week as the US put a 90-day pause on implementing its plan for reciprocal tariffs on a country-by-country basis, but uncertainty remains, particularly for certain trading partners, notably China. What is the impact on the pharma industry and what may in store.

    By Patricia Van Arnum Verified · DCAT Value Chain Insights

    Apr. 10, 2025

As seen in

Company Info

DCAT Value Chain Insights

Robbinsville, New Jersey, United States